Jörn Sträter

2.7k total citations
40 papers, 1.9k citations indexed

About

Jörn Sträter is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Jörn Sträter has authored 40 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Immunology and 13 papers in Oncology. Recurrent topics in Jörn Sträter's work include Cell death mechanisms and regulation (12 papers), Cell Adhesion Molecules Research (7 papers) and Lung Cancer Treatments and Mutations (6 papers). Jörn Sträter is often cited by papers focused on Cell death mechanisms and regulation (12 papers), Cell Adhesion Molecules Research (7 papers) and Lung Cancer Treatments and Mutations (6 papers). Jörn Sträter collaborates with scholars based in Germany, France and Italy. Jörn Sträter's co-authors include Peter Möller, K Koretz, Henning Walczak, Peter H. Krammer, Peter Mӧller, S Riedl, Andreas R. Günthert, Andrea Tandara, Cornelia Hasel and Ulrich Wedding and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Cell Biology.

In The Last Decade

Jörn Sträter

38 papers receiving 1.8k citations

Peers

Countries citing papers authored by Jörn Sträter

Since Specialization

Citations

This map shows the geographic impact of Jörn Sträter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörn Sträter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörn Sträter more than expected).

Fields of papers citing papers by Jörn Sträter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörn Sträter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörn Sträter. The network helps show where Jörn Sträter may publish in the future.

Co-authorship network of co-authors of Jörn Sträter

This figure shows the co-authorship network connecting the top 25 collaborators of Jörn Sträter. A scholar is included among the top collaborators of Jörn Sträter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörn Sträter. Jörn Sträter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prospective trial of immuno(chemo)therapy before resection, definitive chemoradiotherapy or palliative therapy in patients with locally advanced or oligometastatic non-small cell lung cancer without a primary curative option 2021 ·European Journal of Cancer ·Martin Faehling, (unknown), (unknown), Jörn Sträter, S. Eschmann, (unknown), Frank Heinzelmann	5
2	Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice 2018 ·Journal of Cancer Research and Clinical Oncology ·Martin Faehling, (unknown), (unknown), (unknown), Matthias Leschke, Jörn Sträter, R. Eckert	10
3	P3.02b-109 Molecular Profiling of EGFR-Positive NSCLC with Secondary T790M Resistance Mutation and Tertiary Transformation into Small-Cell Lung Cancer 2017 ·Journal of Thoracic Oncology ·Martin Faehling, Anna‐Lena Volckmar, Albrecht Stenzinger, (unknown), (unknown), Jörn Sträter	0
4	Caspase 14 does not influence intestinal epithelial cell differentiation 2013 ·Cell Death and Differentiation ·Jakob Benedict Seidelin, Jörn Sträter, Ole Haagen Nielsen	3
5	Expression and prognostic significance of APAF‐1, caspase‐8 and caspase‐9 in stage II/III colon carcinoma: Caspase‐8 and caspase‐9 is associated with poor prognosis 2009 ·International Journal of Cancer ·Jörn Sträter, (unknown), (unknown), Ulf Hinz, Jürgen Weitz, Peter Möller	40
6	Impaired CD95 expression predisposes for recurrence in curatively resected colon carcinoma: clinical evidence for immunoselection and CD95L mediated control of minimal residual disease 2005 ·Gut ·Jörn Sträter, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	52
7	Parenchymal regression in chronic pancreatitis spares islets reprogrammed for the expression of NFκB and IAPs 2005 ·Laboratory Investigation ·Cornelia Hasel, Umesh Bhanot, (unknown), Jörn Sträter, Peter Möller	17
8	Functional Expression of the Interleukin-11 Receptor α-Chain and Evidence of Antiapoptotic Effects in Human Colonic Epithelial Cells 2004 ·Journal of Biological Chemistry ·Stephan Kießling, Gerhard Müller‐Newen, Sandra N. Leeb, Martin Hausmann, Heiko C. Rath, Jörn Sträter, Tanja Spöttl, Klaus Schlottmann, Johannes Grossmann, Félix A. Montero‐Julian, Jürgen Schölmerich, Tilo Andus, Armin Buschauer, Peter C. Heinrich, Gerhard Rogler	56
9	In Chronic Pancreatitis, Widespread Emergence of TRAIL Receptors in Epithelia Coincides with Neoexpression of TRAIL by Pancreatic Stellate Cells of Early Fibrotic Areas 2003 ·Laboratory Investigation ·Cornelia Hasel, Susanne Dürr, Bettina Rau, Jörn Sträter, Roland M. Schmid, Henning Walczak, Max G. Bachem, Peter Möller	31
10	TRAIL and its receptors in the colonic epithelium: A putative role in the defense of viral infections 2002 ·Gastroenterology ·Jörn Sträter, Henning Walczak, (unknown), Lutz von Müller, Cornelia Hasel, Marko Kornmann, Thomas Mertens, Peter Möller	75
11	Mesothelial Cells in Suspension Expose an Enriched Integrin Repertoire Capable of Capturing Soluble Fibronectin and Laminin 2002 ·Cell Communication & Adhesion ·Thomas F.E. Barth, N. Rinaldi, Silke Brüderlein, Gunhild Mechtersheimer, Jörn Sträter, Peter Altevogt, (unknown)	11
12	CD95 ligand (CD95L) immunohistochemistry: a critical study on 12 antibodies 2001 ·Cell Death and Differentiation ·Jörn Sträter, Henning Walczak, Cornelia Hasel, Ingo Melzner, Frank Leithäuser, Peter Mӧller	42
13	Expression and Function of Death Receptors and Their Natural Ligands in the Intestine 2000 ·Annals of the New York Academy of Sciences ·Jörn Sträter, Peter Möller	36
14	Rhinolith of the nasal septum 2000 ·International Journal of Pediatric Otorhinolaryngology ·Tilman Keck, (unknown), Jörn Sträter, Ajnacska Rozsasi	17
15	CD95 Ligand (CD95L) in Normal Human Lymphoid Tissues 1999 ·American Journal Of Pathology ·Jörn Sträter, Sara M Mariani, Henning Walczak, Frank G. Rücker, Frank Leithäuser, Peter H. Krammer, (unknown)	33
16	Radiocontrast-induced DNA fragmentation of renal tubular cells in vitro: role of hypertonicity 1998 ·Nephrology Dialysis Transplantation ·István Hizoh, Jörn Sträter, (unknown), W. Kübler, Christlieb Haller	74
17	Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients. 1997 ·Journal of Clinical Oncology ·Mario Lazzarino, Ester Orlandi, Marco Paulli, Jörn Sträter, Catherine Klersy, Umberto Gianelli, Livio Gargantini, (unknown), Maria Antonietta Gambacorta, Ester Marra, Thierry Lavabre‐Bertrand, Umberto Magrini, C. Manegold, Carlo Bernasconi, Peter Mӧller	114
18	Clinical stable systemic mastocytosis with interferon alpha 2b therapy. 1997 ·Journal of Internal Medicine ·Christoph Hübner, Ulrich Wedding, Jörn Sträter, Bernd Limberg, Wolfgang Stremmel	15
19	Simultaneous in situ detection of mRNA and apoptotic cells by combined hybridization and TUNEL. 1996 ·Journal of Histochemistry & Cytochemistry ·Jörn Sträter, Henning Walczak, Peter H. Krammer, Peter C. Möller	16
20	In situ detection of enterocytic apoptosis in normal colonic mucosa and in familial adenomatous polyposis. 1995 ·Gut ·Jörn Sträter, K Koretz, Andreas R. Günthert, Peter Mӧller	113

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact